Table 5.
Results of the multivariate logistic regression of effusion
| Index | Univariable analysis | Multivariate analysis | ||
|---|---|---|---|---|
| P-value | OR (95% CI) | P-value | OR (95% CI) | |
| AST (normal/abnormal) | 0.006 | 2.513 (1.302–4.852) | 0.047 | 2.060 (1.008–4.210) |
| GGT (normal/abnormal) | 0.002 | 2.813 (1.456–5.434) | 0.292 | 1.405 (0.637–3.102) |
| TBIL (normal/abnormal) | 0.037 | 2.071 (1.043–4.112) | 0.196 | 1.469 (0.518–4.170) |
| DBIL | 0.008 | 1.094 (1.024–1.170) | 0.195 | 1.031 (0.9320–1.142) |
| SCr | 0.019 | 0.971 (0.948–0.995) | 0.164 | 0.981 (0.967–1.007) |
| HBV-DNA (normal/abnormal) | 0.042 | 2.286 (1.032–5.064) | 0.360 | 1.835 (0.699–4.823) |
| Tumor size | <0.001 | 1.066 (1.032–1.101) | <0.001 | 1.065 (1.030–1.102) |
| Vs | 0.029 | 1.945 (1.072–3.528) | 0.374 | 0.463 (0.082–2.609) |
| E | 0.019 | 1.056 (1.009–1.105) | 0.443 | 0.979 (0.861–1.113) |
| F index | 0.006 | 1.897 (1.206–2.982) | 0.021 | 1.773 (1.089–2.888) |
Abnormal AST: AST>37 U/L; abnormal GGT: GGT>50 U/L; abnormal TBIL: TBIL>22 µmol/L.
Bold values indicate statistical significance if P < 0.05.
AST, aspartate aminotransferase; CI, confidence interval; DBIL, direct bilirubin; F index, fibrosis index; GGT, γ-glutamyl transpeptidase; HBV, hepatitis B virus; OR, odds ratio; SCr, serum creatinine; TBIL, total bilirubin.